Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00519-4/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsmi=296902429&_hsenc=p2ANqtz--EuBeOP7Rw0KkWU3xWyph3918LK3nBUrwkdS8eTE1TyY3zYt2RCC34Cht0B4nM_VmIYGpbzsF4AJQ5MCqVRzxLXQwXYg&utm_content=296876699&utm_source=hs_email